Morning digest: Covaxin taken off clinical trial mode; Modi to attend virtual summit of Quad today, and more
The Hindu
India’s indigenous COVID-19 vaccine Covaxin from Hyderabad-based Bharat Biotech has been taken off the clinical trial mode and is now authorised for emergency use on a par with Oxford-AstraZeneca’s Covishield, NITI Aayog’s member (health) V.K. Paul said on Thursday.
More Related News













